Stay updated on GARNET: Anti-PD-1 Antibody Clinical Trial
Sign up to get notified when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.

Latest updates to the GARNET: Anti-PD-1 Antibody Clinical Trial page
- CheckyesterdayChange DetectedA banner announces an NIH terminology transition, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision label updates from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page that previously displayed the study details now shows a 403 Forbidden error, meaning the study record is inaccessible and the usual content is replaced by an error screen.SummaryDifference21%

- Check36 days agoChange DetectedThe revision label on the page was updated from v3.6.6 to v3.7.0. This indicates a newer revision of the study record.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a new iteration of the page content.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded numerous study sites across multiple countries (including the UK, Spain, South Korea, Brazil, Argentina, Mexico, Poland, and the United States) and removed a few previously listed locations. The total number of locations now listed is 128.SummaryDifference2%

Stay in the know with updates to GARNET: Anti-PD-1 Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.